EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The IMA-PLUS Score for Predicting Type 2 Endoleak After Endovascular Repair: Development and External Validation in European and Japanese Cohorts

Johannes Hatzl, Edris El-Sanosy, Samuel Kilian, Alexandru Barb, Louisa Bornhak, Hirotsugu Ozawa, Takao Ohki, Dittmar Böckler, ZEPHYR Study Group collaborators

European Journal of Vascular and Endovascular Surgery · 2026-11

DOI: 10.1016/j.ejvs.2026.11.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Vascular and Endovascular Surgery, 2026-11. Verfasst von Johannes Hatzl und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular and Endovascular Surgery, University Hospital Heidelberg, Heidelberg, Germany. Electronic address: johannes.hatzl@med.uni-heid…. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dietmar Hopp Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Prophylactic embolisation of infrarenal branch vessels has been investigated to prevent type 2 endoleak (EL2) following endovascular repair (EVAR) of abdominal aortic aneurysms (AAA), but patient selection is poorly defined. In this study, a computed tomography angiography (CTA) based risk score was developed and validated to predict EL2 after EVAR. METHODS: This multicentre, retrospective diagnostic study used prospectively collected data from the Zenith alpha for aneurysm Repair Registry (ZEPHYR) as the development cohort. Eligible patients underwent standard EVAR with pre-operative arterial phase CTA and at least one post-operative delayed phase CTA. The model was converted into a numerical score ("IMA-PLUS Score") and validated in two retrospective cohorts. Discrimination, calibration, and risk group thresholds were assessed. In validation cohorts, freedom from AAA expansion and EL2 associated reinterventions up to 5 years were analysed. RESULTS: Data from 245 patients of the ZEPHYR registry were included. EL2 occurred in 96 patients (39.2%). The IMA-PLUS Score includes inferior mesenteric artery diameter, number of infrarenal renal pole arteries, number of patent lumbar arteries, and median sacral artery patency, achieving a crossvalidated area under the curve (AUC) of 0.78. Using prespecified thresholds (low 200), observed EL2 incidences in ZEPHYR were 19%, 59%, and 74%. In the Heidelberg cohort (n = 134; EL2 44%), AUC was 0.77 (95% confidence intervals [CI] 0.69 - 0.85) with EL2 incidences of 24%, 60%, and 89% across risk groups with good calibration; interobserver agreement for total score was high (intraclass correlation coefficient of 0.95). In the Tokyo cohort (n = 123; EL2 52.8%) AUC was 0.75 (95% CI 0.67 - 0.84); EL2 incidences were 36%, 76%, and 80%, with higher observed incidence than predicted. In validation cohorts, the IMA-PLUS Score was associated with AAA expansion and reduced freedom from EL2 associated reinterventions. CONCLUSION: The IMA-PLUS Score may support selection of patients for future studies on preventive management strategies.

Schlagwörter

Stichwörter der Autor:innen

Abdominal aortic aneurysmComputed tomography angiographyEndovascular repairProphylactic embolisationRisk scoreType 2 endoleakValidation

Autor:innen und Institutionen

  • Department of Vascular and Endovascular Surgery, University Hospital Heidelberg, Heidelberg, Germany. Electronic address: johannes.hatzl@med.uni-heidelberg.de.
  • Department of Vascular and Endovascular Surgery, University Hospital Heidelberg, Heidelberg, Germany.
  • Institute of Medical Biometry, University of Heidelberg, Heidelberg, Germany.
  • Division of Vascular Surgery, Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.

Förderung

  • Dietmar Hopp Foundation

Zitieren

APA

Hatzl, J., El-Sanosy, E., Kilian, S., Barb, A., Bornhak, L., Ozawa, H., Ohki, T., Böckler, D., & ZEPHYR Study Group collaborators (2026). The IMA-PLUS Score for Predicting Type 2 Endoleak After Endovascular Repair: Development and External Validation in European and Japanese Cohorts. European Journal of Vascular and Endovascular Surgery. https://doi.org/10.1016/j.ejvs.2026.11.003

Vancouver

Hatzl J, El-Sanosy E, Kilian S, Barb A, Bornhak L, Ozawa H, et al. The IMA-PLUS Score for Predicting Type 2 Endoleak After Endovascular Repair: Development and External Validation in European and Japanese Cohorts. European Journal of Vascular and Endovascular Surgery. 2026. doi:10.1016/j.ejvs.2026.11.003

BibTeX
@article{Hatzl2026,
  author = {Hatzl, Johannes and El-Sanosy, Edris and Kilian, Samuel and Barb, Alexandru and Bornhak, Louisa and Ozawa, Hirotsugu and Ohki, Takao and Böckler, Dittmar and ZEPHYR Study Group collaborators, ZEPHYR Study Group collaborators},
  title = {The IMA-PLUS Score for Predicting Type 2 Endoleak After Endovascular Repair: Development and External Validation in European and Japanese Cohorts},
  journal = {European Journal of Vascular and Endovascular Surgery},
  year = {2026},
  doi = {10.1016/j.ejvs.2026.11.003}
}
Kostenlos starten →